Structure Therapeutics (NASDAQ: GPCR) recently received a number of ratings updates from brokerages and research firms: 3/28/2026 – Structure Therapeutics was downgraded by Wall Street Zen from “hold” to “sell”. 3/26/2026 – Structure Therapeutics is now covered by Wolfe Research. They set a “peer perform” rating on the stock. 3/17/2026 – Structure Therapeutics was given [...]
Research Analysts’ Recent Ratings Changes for Structure Therapeutics (GPCR)
